Peptides and exfoliating acids cannot be encompassed by a single universal compatibility rule. „Peptide” refers to a vast family of amino acid chains with different sequences and chemical properties, whereas „acid” is a broader chemical term encompassing substances with completely different structures, applications, and formulation requirements. Therefore, whether a particular peptide and acid can function well together depends on a much larger number of factors than just the category name itself.
Among other things, the exact identity of the peptide, the type of acid, their concentration, pH, the buffer system, the exposure conditions, and the entire formulation are important. It is also necessary to distinguish between two completely different questions: whether the peptide and the acid can be effectively combined in one professionally formulated cosmetic product, and whether two independently produced skincare products can be mixed or applied one on top of the other.
Published studies show why simple rules can be misleading. Scientists analyzed multicomponent formulations containing both acids and peptides, and more recent work concerned a specially designed system based on an acid derivative whose goal was to improve the delivery of the peptide. [1][2] These results make it difficult to scientifically justify the broad statement that „all acids immediately destroy all peptides”.
At the same time, these studies do not prove that any product containing acid can be combined without restrictions with any peptide serum.
The deliberately formulated formulation is something completely different from mixing two ready-made products that were created independently.
Therefore, the assessment of the compatibility of peptides with acids requires a distinction. chemical stability, physical compatibility of formulations, skin tolerance, and clinical efficacy. These issues are related to each other, but they do not mean the same thing.
AHA, BHA and other acids
What exactly do these categories mean?
Alpha-hydroxy acids, most commonly referred to by the abbreviation AHA, They include, among others, glycolic acid and lactic acid. They are commonly used in cosmetics intended to affect the surface and texture of the skin and the exfoliation process, although hydroxyacids can also serve other functions in the formulation.
The mere presence of AHA in the list of ingredients does not yet indicate how intensively the finished product will work as an exfoliant.
The FDA indicates that the significance for the efficacy of cosmetics containing AHA includes, among other things: type of acid, its concentration, pH and other components of the formulation. [3] Two products containing the same acid may therefore behave differently, because the entire formulation differs between them.
In cosmetic terminology, the abbreviation BHA It usually refers to salicylic acid.
There is, however, an important chemical nuance. Salicylic acid is an aromatic hydroxyacid, not the classical aliphatic beta-hydroxyacid. The FDA also distinguishes its technical chemical classification from the way the term BHA is commonly used in cosmetics. [4]
For a person analyzing a cosmetic product, a specific ingredient name is therefore more informative than the mere assumption that all products labeled as „BHA” create an identical chemical and formulation environment.
Products containing polyhydroxy acids, i.e. PHA, They often use substances such as glucolonic acid, which in the presence of water can form gluconic acid. Their chemical structure contains many hydroxyl groups, which distinguishes them from simpler hydroxyacids.
However, mere structural differences do not prove that every PHA product is automatically gentle, non-irritating, or compatible with every peptide.
In a controlled study of glukonolactone, a specific formulation was analyzed in a specific clinical population.[5] The results pertain to this intervention and should not be generalized as a universal principle for all possible combinations of PHA and peptides.
Azelain acid belongs to a different category
Azelaic acid clearly shows why the broad term „acid” It can lead to misunderstandings in discussions about skin care.
In terms of chemistry, azelaic acid is dicarboxylic acid. It is not part of the AHA and is not a substance that is usually referred to as BHA.
Azelaine acid has been extensively studied in the context of dermatology, but the results regarding the azelaine acid preparation cannot simply be substituted with data regarding glycolic acid, salicylic acid, or other chemically different acids.
For example, in a randomized controlled clinical study, azelaic acid cream was evaluated in people with the follicular-nodular form of rosacea. [6]
The study provides information regarding specific preparation, population, disease and evaluated results.
It does not prove that a cosmetic not related to this study, advertised as an „ampoule containing azelaic acid and peptides,” treats rosacea.
It also does not specify how such a vial should be combined with another cosmetic product.
The common name „azelaic acid” is insufficient to demonstrate the equivalence of formulations, concentrations, methods of administration, or exposure.
Not every ingredient containing the word „acid” is exfoliating.
One of the most important distinctions in cosmetic chemistry is that the term „acid” does not automatically mean „a substance that exfoliates”.
A good example is hyaluronic acid combined with peptides. Hyaluronic acid is a carbohydrate polymer widely used in formulations aimed at moisturizing. It does not belong to the same functional category as glycolic acid just because the word „acid” is also included in its name.
Amino acids, on the other hand, are the molecules from which peptides are formed.
Fatty acids are an important component of lipid chemistry.
None of these groups should be automatically placed in the same category as glycolic or salicylic acid exfoliants.
Even well-known hydroxyacids, such as citric or lactic acid, can sometimes be used partially or primarily to regulate the pH of formulations, rather than for intensive exfoliation.[3]
Therefore, the concentration, the intended function of the component, and the entire formulation are important.
Compatibility table that automatically places each component containing the word „acid” in the same category of warnings, it ignores these differences before the peptide itself is evaluated.
Clinical effects depend on the acid and the formulation
Different acids and different formulations can lead to different clinical outcomes.
In a 22-week randomized study involving 74 women, a cream with glycolic acid, a cream with L-lactic acid, and a placebo were compared in people with skin damaged by sunlight. Both active formulations improved selected clinical parameters, but the pattern of results differed depending on the evaluated parameter and the body area. [7]
This confirms an important principle: The formulations studied should be considered as specific interventions, rather than representatives of all cosmetics containing acids.
The study also did not analyze the connection with the peptide.
It may help to understand why the type of acid, formulation, and choice of endpoints are important, but it does not answer the question of whether specific peptide serums can be used directly before or after one of these acids.
To do this, a different research question and different data would be needed.
Why are concentration and pH important?
Concentration and pH describe different properties
Concentration and pH are treated as if they determine the same characteristic of a product containing acid.
That is not the case.
The concentration determines the amount of a specific substance present in a preparation, while the pH describes the acidity or alkalinity of the corresponding aquatic environment.
Two products can therefore declare the same percentage of a given acid, while having different pH values, different buffer systems, different solvents, and different ratios of the ionized and non-ionized forms of the acid.
In the case of weak acid, the balance between the ionized and non-ionized form depends, among other things, on the pH in relation to the dissociative properties of the compound.
This is an important chemical principle, but it still does not allow for predicting the clinical behavior of the entire cosmetic product based on a single value.
Buffers, solvents, excipients, the amount of product applied, contact time and the physical properties of the substrate can all influence exposure.
Lower pH should not therefore be automatically interpreted as a universal indicator of greater effectiveness.
Clinical studies have analyzed glycolic acid preparations with different concentrations and pH values for dry, xerotic, or fish-scaled skin. [8] The results did not confirm the simple assumption that the lowest pH must automatically provide the best result.
The specific clinical context of these studies also means that the results should not be automatically applied to all facial peelings.
The changes in peptides depend on the sequence and conditions
Peptides can undergo various chemical transformations under the influence of the environment, but not all peptides degrade in the same way or at the same rate.
The significance lies in the amino acid sequence itself.
In one model study of heksapentapeptide, it was shown that deamidation depended, among other things, on pH, temperature, and the composition of the buffer. The chemical mechanism also differed between acidic conditions and an environment with a higher pH.[9]
Separate studies of model pentapeptides showed that adjacent amino acid residues influenced the degradative behavior, and the relative rate of metabolism varied depending on pH.[10]
These are controlled chemical studies, not experiments involving consumers applying several cosmetics to their skin.
Their significance lies in demonstrating the basic principle of peptide chemistry: The reaction of a particular peptide to its environment depends on its sequence and the conditions of exposure..
Therefore, it cannot be assumed that every cosmetic peptide reacts identically to an acidic environment.
The terminology used to describe degradation is also important.
Deamination is not automatically synonymous with the complete destruction of the peptide.
Deamination changes a specific chemical group in the side chain. It does not necessarily mean that all peptide bonds have been broken, and the molecule immediately breaks down into individual amino acids.
Under certain conditions, peptide bond cleavage may occur, but such a process requires separate evidence.
Therefore, defining any chemical change associated with an acidic environment as „destruction of the peptide” it may obscure important chemical differences.
Stability during storage is not the same as short contact with the skin
The classic stability study and the short-term contact that occurs when two cosmetics are applied to the skin are two different experimental scenarios.
In the stability study, the formulation can remain in the packaging for weeks or months under controlled conditions of temperature, humidity, and light.
The application of two separate products to the skin creates a changing surface environment, where the separately formulated formulations interact at different times and under different physical conditions.
Data regarding the long-term stability of the product in the package cannot therefore be directly converted into a precise prediction regarding short-term contact with the skin.
The reverse assumption is equally problematic.
The fact that the contact between two applied products can be relatively brief does not prove that every combination will remain chemically stable, physically compatible, and well-tolerated.
The most valuable study of a specific compound should analyze the actual formulations under realistic conditions and measure relevant parameters such as the remaining peptide concentration, degradation products, or functional properties.
Without such data, both extreme claims — „the peptide is immediately destroyed” and „the acid has no effect on the peptide” — may go beyond the available evidence.
Laboratory studies of formulations containing acetyl hexapeptide-8 show a more appropriate analytical approach. Scientists used chemical, rheological, and release studies to evaluate the peptide in specific environments.[11]
This shows why data regarding a specific formulation are more informative than conclusions based solely on the words „peptide” and „acid”.
We also describe more about the influence of the environment, temperature and other conditions on the stability of peptides in an article about Storage of peptides.
The pH itself does not measure irritation
Chemical stability and skin tolerance are two different questions.
The peptide may remain chemically detectable in the formulation, while the finished product will still cause irritation in some people.
On the other hand, a cosmetic product may be comfortable for the skin, but that does not mean that every active ingredient has retained its original concentration, structure, or biological activity.
The pH measurement alone does not allow determining the full safety profile of the product, its long-term stability, or its clinical effectiveness.
pH is one of the many important formulation parameters.
Home pH measurements have even more limitations. They will not detect peptide degradation products, they will not accurately characterize the behavior of the buffering system during application, they will not confirm physical compatibility, and they will not indicate which component is responsible for irritation.
A peptide and an acid in one formulation, but two separate products
The ready formulation is a specific intervention
The finished cosmetic product can be deliberately formulated with consideration for a specific pH, solvent system, ingredient concentration, base, and packaging.
The manufacturer can then evaluate this specific formulation in terms of stability, physical properties, tolerance, and potential clinical efficacy.
This is fundamentally a different situation than combining two ready-made cosmetics developed separately, whose mutual effects have not been formally evaluated.
In a prospective, eight-week study, gel for local application containing retinoids, antimicrobial peptide, salicylic acid, glycolic acid and niacinamide in people with mild acne. 25 participants were included in the study, 22 of whom completed the follow-up. [1]
This is an important example because it shows that acids and peptides were studied together in a deliberately formulated product for local use.
However, the study was small, and the formulation contained many active ingredients.
No comparison was used to isolate the individual components and determine which of them was responsible for each observed effect.
More importantly, the study does not prove that every acid can be effectively combined with every peptide.
It only shows that One specific multicomponent formulation was tested.
Since other ingredients may also be present in such products at the same time, it is worth evaluating the evidence separately for combinations such as peptides and niacinamide or peptides and retinol, Instead of assuming that the result of one product automatically applies to every similar combination.
The specially designed delivery system is not just a simple product delivery system.
More advanced formulation studies show this difference even more clearly.
A 2025 study was developed a jointly organized system that combines an ionic liquid derived from apple acid with acetyl hexapeptide-8. The study included laboratory experiments regarding the delivery of the substance, cellular studies, and a brief clinical evaluation of the face cream.[2]
According to the abstract, the designed combination improved the delivery of the peptide and yielded the selected wrinkle-reducing results compared to the peptide preparation used as a reference point.
The study is directly relevant to the study of peptide formulations.
However, this does not prove that a similar environment can be recreated by using a conventional exfoliating cosmetic containing apple acid under an independently produced serum containing acetyl hexapeptide-8.
Specially designed ionic liquid differs chemically and functionally from a typical exfoliating product.
The study therefore shows what the formulation technology can achieve under certain conditions.
It does not create a universal rule regarding the layering of products.
The abstract itself also leaves some methodological issues that would require a full publication analysis before the final assessment of the strength of the clinical conclusions can be made.
Products that are rinsed off and remain on the skin create different exposure conditions.
The form of the product affects the exposure.
The cleansing product containing the acid is usually removed from the skin after the intended contact time has elapsed.
The serum or leave-on cream, on the other hand, remains on the skin according to the product instructions.
Even if both cosmetics contain the same acid, they can differ significantly. sometimes contact, concentration, auxiliary components, substrate and purpose.
Therefore, the results regarding the cream left on the skin cannot be automatically transferred to a cleansing product containing glycolic acid and peptide.
Similarly, the presence of a peptide in a cleansing product is not a scientific justification for leaving it on the skin for longer than the instructions specify.
The conditions of application are part of the intervention.
Their change leads to a different type of exposure than the one for which the product was designed or tested.
„Compatibility” can mean several different things
The word „compatible” It is often used as if it describes one feature. In practice, it can refer to several different questions.
If we ask whether the ingredients remain chemically unchanged, appropriate stability analyses of the specific formulation are required.
If the question concerns the physical utility of the mixture, it should be evaluated, among other things, the separation of phases, sedimentation, change in viscosity, and other physical properties.
As for the appropriate microbiological protection of the product, a proper microbiological assessment of the finished formulation is required.
Tolerance of the intended method of use requires appropriate studies in humans.
However, the question of whether the combination improves the claimed effect requires a properly designed controlled clinical trial.
A positive result from one type of test does not automatically mean a positive result from all the other types.
Chemical stability does not prove clinical effectiveness.
Physical stability does not guarantee good tolerance.
Good tolerance does not mean that all the active ingredients remain chemically unchanged.
A reliable statement regarding compatibility should therefore specify:, which specific type of compatibility was examined.
Exaggeration and limitations of available evidence
Different acids do not have the same effect on the skin's reaction to UV.
It should not be assumed that all acids elicit the same biological response.
In a study involving 14 people, glycolic acid, salicylic acid, the base, and untreated areas of the skin were compared before exposure to simulated sunlight. Under this experiment, glycolic acid increased the measured UV sensitivity, while salicylic acid did not cause significant changes in the evaluated biomarkers. [12]
This is another argument against treating all acids as biologically equivalent.
However, these results should not be interpreted as evidence that salicylic acid acts as a sunscreen or that any product containing this ingredient eliminates the need for adequate sun protection.
The experiment included selected short-term parameters under specific exposure conditions.
It did not assess all products, concentrations, or long-term use scenarios.
The FDA’s information regarding cosmetics containing AHAs includes precautions related to increased sensitivity to the sun. [3]
The addition of a peptide to such a formulation does not automatically mean that this issue ceases to be relevant.
To establish that a peptide prevents the reaction associated with AHA and UV radiation, such protective effects would have to be directly demonstrated, rather than being inferred from the general assumption that peptides have a soothing effect.
Irritation is not evidence of effective exfoliation
Burning, persistent tingling, swelling, or worsening redness should not be interpreted as a sign of particularly effective action of the exfoliating product.
Such reactions do not show how effectively the acid achieves the intended cosmetic effect.
They also do not prove that the peptide initiated the process of „repairing” the skin.
Tolerance is a different endpoint than effectiveness.
The FDA’s information regarding BHA-containing cosmetics recommends following the product instructions and discontinuing use in the event of irritation or prolonged stinging.[4]
Testing a product on a small area of skin can help detect an immediate reaction in some situations, but it does not guarantee future tolerance of all possible combinations.
It also does not replace appropriate evaluation if a significant or persistent reaction occurs.
Small studies do not resolve the issue of all possible connections.
A favorable short-term study of a specific combination cannot rule out all rare adverse reactions.
Similarly, a study conducted in people with mild acne does not automatically describe what will happen in people with rosacea, very reactive skin, healthy skin, or skin after a procedure.
Laboratory testing of a single peptide in a specific buffer cannot represent all peptide serums available on the market.
These limitations do not mean that the research is worthless.
They define, however, boundaries within which results can be reasonably generalized.
The most important thing is to determine whether the material under study, the formulation, the exposure, the population of participants, and the measured effect correspond to the claim that we want to formulate based on the study.
If this is not the case, the evidence should be described as circumstantial rather than presented as conclusive.
How to interpret the instructions for a specific product?
The instruction refers to a specific formulation
Recommendations regarding the frequency of application, rinsing of the product, the application site, and the combination of ingredients should be interpreted in relation to the product. the specific product and its current formulation.
For example, the manufacturer of one serum containing multiple peptides and hyaluronic acid currently lists the directly applied acids and salicylic acid among the products that should not be combined with this specific serum.[13]
This is useful information related to the specific product.
It is not a published scientific proof that every acid immediately destroys every peptide.
At the same time, a clinical study of a completely different formulation containing acid and a peptide is not a reason to ignore the manufacturer's instructions regarding the specific serum.
Both information can be correct because they refer to different formulations.
Similarly, restrictions set by one manufacturer should not be automatically converted into a chemical law covering all peptide products.
If the instructions appear unclear or contradictory, an explanation regarding the matter is more reliable. specific formulations, Instead of creating a universal chemical mechanism.
Universal waiting time would require evidence
The analyzed studies do not establish a single universal waiting time that would guarantee the chemical stability, effectiveness, and good tolerance of each combination of the peptide with the acid.
Waiting a certain number of minutes between products does not prove that the peptide has remained intact.
It also does not invalidate the explicit restriction regarding a specific product.
Distributing products at different times can change the conditions of their exposure and interaction with each other, but in and of itself does not prove that such a scheme has been scientifically tested.
There is also no universal scientific requirement that all peptids and exfoliants must always be applied on different days.
Such schemes may sometimes be proposed for practical reasons or related to tolerance, but they should not be presented as universal chemical laws without data regarding specific products.
It is most justified to take into account the instructions, the properties of the formulations, and the limitations of the products that are actually the subject of the question.
The claim should be proportionate to the evidence
Good information about compatibility is precise.
Statement „this specific formulation containing a peptide and an acid was evaluated under such conditions” It differs scientifically from a statement „all peptides and acids can be safely combined”.
Similarly, the information „The manufacturer of this particular product advises against combining it with directly applied acids.” it is not the same as the statement „low pH immediately destroys any peptide”.
A credible explanation should, if the data are available, specify the peptide, acid, formulation, exposure conditions, and the evaluated effect.
Such precision may not sound as effective as a universal compatibility table, but it provides much more valuable information.
Frequently asked questions
Can all acids be considered as one group of components?
No. Acids differ in chemical structure, function, behavior in formulation, and clinical effects. Even glycolic and salicylic acids caused different UV-related reactions in a controlled human study.[12] Azelaic acid belongs to a different chemical class, whereas hyaluronic acid is a polymer primarily associated with hydration rather than the classic exfoliating hydroxy acid. Compatibility should therefore be evaluated based on the specific substance and formulation, not the common word „acid.”.
Does low pH affect every peptide equally?
No. The reaction of a peptide depends, among other things, on the amino acid sequence, chemical modifications, the surrounding formulation, temperature, buffer composition, and exposure time. Controlled studies of model peptides have shown both pH-dependent chemical transformation pathways and sequence-dependent differences in degradation behavior. [9][10] These experiments do not allow for all cosmetic combinations to be predicted, but they clearly show why all peptides should not be treated as chemically identical.
Can the finished product contain both a peptide and an exfoliating acid at the same time?
Yes. In the published study, a topical preparation containing a antimicrobial peptide together with glycolic acid, salicylic acid and several other ingredients was evaluated.[1] However, the study involved a small group and a multi-ingredient formulation and did not isolate the individual effects of the peptide. It shows that a specially formulated combination can be tested, but does not prove that two independently produced products with acid and peptide can be automatically mixed to achieve the same result.
Does acid immediately break down every peptide into individual amino acids?
No. There is no basis for assuming the immediate and complete breakdown of every peptide into individual amino acids as a universal principle. The chemistry of peptides involves various possible transformations, and processes such as deamination should not automatically be equated with the complete breaking of peptide bonds. Research also shows that pH, sequence, and environmental conditions influence the degradation pathways.[9][10] Therefore, the claim of immediate destruction requires evidence regarding a specific peptide and specific exposure.
Is azelaic acid the same as AHA or BHA?
No. Azelaic acid is a dicarboxylic acid and has its own chemistry, formulation properties, and research literature. The controlled study of azelaic acid concerned a specific dermatological preparation and a specific clinical population. [6] These results cannot be automatically substituted with studies of glycolic or salicylic acid, nor can they be used to confirm the action of an unrelated peptide product simply because it contains azelaic acid.
Is hyaluronic acid an exfoliating acid?
No. Hyaluronic acid is a polysaccharide widely used in moisturizing products and is not a classic exfoliating hydroxy acid. The very word „acid” in the name of the ingredient does not indicate its cosmetic function. Even well-known AHAs can sometimes serve as a pH regulator in a formulation instead of a strong exfoliating ingredient.[3] The function of the ingredient must therefore always be interpreted in the context of the entire formulation.
Does the lowest pH always mean the highest effectiveness?
No. Clinical efficacy cannot be ranked solely based on pH values. Studies comparing glycolic acid preparations with different concentrations and pH levels have not confirmed the simple principle that the lowest pH automatically provides the best result. [8] The medium, concentration, contact conditions, characteristics of the participants, and the measured parameter also play a role. A lower pH value is therefore not a universal measure of effectiveness.
Does the same percentage of acid mean the same „strength” of the product?
No. The percentage value determines the concentration, but it does not itself inform about pH, buffering capacity, solvent system, substrate, or contact time. The FDA lists several of these factors as important for the efficacy of AHA products.[3] Two cosmetics claiming identical acid concentration may therefore behave differently. Assessing the entire formulation and intended use provides more information than comparing one number on the label.
Can a peptide prevent the irritation caused by the acid?
This should not be assumed solely because the product contains a peptide. A study of a multi-ingredient formulation can provide information about the overall tolerance of the entire product, but without proper comparison of the individual components, it cannot be shown that it was the peptide that prevented the acid-induced irritation. [1] Similarly, a specially developed peptide delivery system does not prove its universal soothing effect. A claim of protective action requires direct evidence.
Does pinching mean that the connection is working?
No. The tingling does not indicate peptide activity, effective exfoliation, or a beneficial clinical response. However, persistent tingling or itching may indicate poor tolerance. FDA information regarding BHA cosmetics recommends discontinuing use if irritation or prolonged tingling occurs. [4] The cosmetic efficacy and skin comfort should be evaluated separately. Discomfort should not replace evidence of a product’s beneficial effects.
Can the cleansing product be applied to serum that remains on the skin?
Not automatically. Products that are rinsed off and leave-on serums create different exposure conditions due to the different contact time, base, and method of application. Therefore, clinical studies of acidic creams left on the skin do not automatically demonstrate the same effects of rinsed-off products. [7] Similarly, the presence of a peptide in a cleansing product is not a scientific justification for leaving the product on the skin longer than the instructions specify.
Does a specific waiting time between products guarantee compatibility?
No. The analyzed evidence does not establish a single universal time interval that guarantees the compatibility of all acids and peptides. The stability of a peptide depends on the specific molecule and the chemical environment; however, studies of specific formulation systems do not validate every actual method of applying cosmetics. [11] A waiting period of several or even several dozen minutes cannot be considered evidence of chemical compatibility.
Does the manufacturer's restriction mean that all similar connections are harmful?
No. The manufacturer's restriction applies directly to a specific formulation, unless broader data confirm the effect across the entire category. A single multipeptide product may have a warning instruction against combining with directly applied acids, while separate scientific studies have evaluated deliberately formulated systems that simultaneously contain both acid and peptide. [2][13] This is not contradictory, as they relate to different products and formulations.
Does a specially formulated acid-peptide carrier confirm the conventional application of cosmetic layers?
No. The specially developed delivery system is a separate formulation technology. The study of the apple acid derivative and acetyl hexapeptide-8 concerned a co-developed delivery system. [2] It did not analyze conventional exfoliating cosmetics applied before an independent peptide serum. Similar ingredient names do not indicate the same chemical exposure.
Does adding peptides remove the sun precautions with AHA?
No. The presence of the peptide does not prove that the issues related to the effect of AHA on skin sensitivity to UV no longer matter. In a human study, increased UV sensitivity was observed with a specific formulation of glycolic acid, and the FDA includes sun safety precautions for products containing AHA. [3][12] Demonstrating that the peptide prevents such an effect would require direct evidence of this interaction.
Can a chemically stable formulation still irritate the skin?
Yes. Chemical stability and tolerance in humans describe different properties. Analytical studies of formulations can assess the integrity of the peptide, its rheology or its release, whereas irritation and tolerance must be studied under appropriate human use conditions. [11] The product can therefore remain chemically stable while causing irritation in some people. On the other hand, the absence of discomfort does not prove complete chemical stability.
What information is most important when evaluating compatibility?
The most useful information is specified the exact peptide, the exact acid, the specific formulation or finished product, the concentration, the anticipated exposure, the current manufacturer's instructions, and available data on stability and human studies. Published studies of acid–peptide combinations show why formulation details are important, but they do not apply to every unexplored combination. [1][2] A precise answer that clearly indicates what has been studied and what is unknown is more scientifically reliable than a universal compatibility table for entire categories of ingredients.
Summary
Peptides and exfoliating acids are required an interpretation referring to a specific component and a specific formulation, rather than a single universal compatibility rule.
The type of acid, the peptide sequence, the concentration, pH, the buffer system, the contact time and the intended use of the product can all influence the formulation's performance. At the same time, chemical stability, physical compatibility, microbiological protection, skin tolerance, and clinical efficacy are separate issues requiring different types of evidence.
Published studies show that peptides and acids can coexist in deliberately formulated formulations. A multicomponent preparation containing an antimicrobial peptide together with glycolic and salicylic acid was clinically tested, and a specially designed system based on an apple acid derivative was evaluated as a method of delivering acetyl hexapeptide-8.[1][2]
These studies are important because they challenge the overly simplistic claim that any acid immediately destroys any peptide.
However, they do not prove the opposite universal principle.
A professionally formulated acid-peptide formulation cannot be automatically reproduced by layering two independently produced cosmetics. Similarly, laboratory data regarding the stability of a single peptide do not determine the behavior of all peptide sequences in any cosmetic environment.
Also, the broad category of „acids” requires careful interpretation. Glycolic, lactic, salicylic, azelaic, hyaluronic and fatty acids do not form a chemically or functionally homogeneous group simply because the same word appears in their names.
A similar principle applies to other combinations of popular skincare ingredients, such as: peptides and ceramides, peptides and vitamin C, peptides and retinol or peptides and niacinamide. The mere presence of two ingredients in one skincare regimen is not evidence of their synergy, incompatibility, or greater effectiveness.
The most reliable statement regarding compatibility should therefore remain narrow and based on evidence: it is necessary to specify the specific peptide, specific acid, finished formulation or product, the exposure conditions and the result that was actually tested.
If no direct data are available, the uncertainty should remain clearly indicated.
Neither a total ban on combining ingredients nor the assumption of full compatibility is justified solely by the names of the categories of ingredients.
Disclaimer
This article is for educational and scientific information purposes only. It explains issues related to the formulation of cosmetics, the chemistry of peptides and acids, the interpretation of studies, and the limitations of the available evidence. It does not present an individual skincare regimen, does not constitute medical or dermatological advice, and does not contain instructions for combining specific products.
Studies involving a deliberately formulated peptide-acid formulation, a special delivery system, laboratory experiments on peptide stability, or a specific clinical product containing the acid should not be automatically interpreted as evidence that unrelated commercial products can be mixed or applied in layers with the same result.
Similarly, the absence of a demonstrated interaction in one formulation does not prove universal compatibility between all peptides, acids, concentrations, substrates, and skin types.
Instructions specific to a particular product remain relevant because manufacturers can develop and test their formulations under conditions significantly different from those used in independent scientific publications.
Persistent burning, significant irritation, swelling, worsening rash, or other serious skin reactions may require evaluation by a suitably qualified specialist instead of further experimentation with combinations of cosmetic ingredients.
References
- Villani, A., Annunziata, M. C., Cinelli, E., Donnarumma, M., Milani, M., & Fabbrocini, G. (2020). Efficacy and safety of a new topical gel formulation containing retinol encapsulated in glycospheres and hydroxypinacolone retinoate, an antimicrobial peptide, salicylic acid, glycolic acid and niacinamide for the treatment of mild acne: Preliminary results of a 2-month prospective study. Giornale Italiano di Dermatologia e Venereologia, 155(5), 676–679. https://doi.org/10.23736/S0392-0488.20.06581-5
- Wang, Z., Zhang, L., Wang, B., Wang, M., & Zhang, J. (2025). Dual-function supramolecular system of α-hydroxy acid-based ionic liquids and peptides for enhanced anti-aging transdermal delivery. Journal of Materials Chemistry B, 13(30), 9286–9293. https://doi.org/10.1039/d5tb00580a
- U.S. Food and Drug Administration. (n.d.). Alpha hydroxy acids. Retrieved September 25, 2026, from https://www.fda.gov/cosmetics/cosmetic-ingredients/alpha-hydroxy-acids
- U.S. Food and Drug Administration. (n.d.). Beta hydroxy acids. Retrieved September 25, 2026, from https://www.fda.gov/cosmetics/cosmetic-ingredients/beta-hydroxy-acids
- Hunt, M. J., & Barnetson, R. S. (1992). A comparative study of gluconolactone versus benzoyl peroxide in the treatment of acne. Australasian Journal of Dermatology, 33(3), 131–134. https://doi.org/10.1111/j.1440-0960.1992.tb00100.x
- Bjerke, R., Fyrand, O., & Graupe, K. (1999). Double-blind comparison of azelaic acid 20% cream and its vehicle in the treatment of papulo-pustular rosacea. Acta Dermato-Venereologica, 79(6), 456–459. https://doi.org/10.1080/000155599750009906
- Stiller, M. J., Bartolone, J., Stern, R., Smith, S., Kollias, N., Gillies, R., & Drake, L. A. (1996). Topical 8% glycolic acid and 8% L-lactic acid creams for the treatment of photodamaged skin. A double-blind vehicle-controlled clinical trial. Archives of Dermatology, 132(6), 631–636. https://pubmed.ncbi.nlm.nih.gov/8651713/
- DiNardo, J. C., Grove, G. L., & Moy, L. S. (1996). Clinical and histological effects of glycolic acid at different concentrations and pH levels. Dermatological Surgery, 22(5), 421–424. https://doi.org/10.1111/j.1524-4725.1996.tb00341.x
- Patel, K., & Borchardt, R. T. (1990). Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide. Pharmaceutical Research, 7(7), 703–711. https://doi.org/10.1023/a%3A1015807303766
- Goolcharran, C., Stauffer, L. L., Cleland, J. L., & Borchardt, R. T. (2000). The effects of a histidine residue on the C-terminal side of an asparaginyl residue on the rate of deamidation using model pentapeptides. Journal of Pharmaceutical Sciences, 89(6), 818–825. https://doi.org/10.1002/%28SICI%291520-6017%28200006%2989%3A6%3C818%3A%3AAID-JPS14%3E3.0.CO%3B2-8
- Ruiz, M. A., Clares, B., Morales, M. E., Cazalla, S., & Gallardo, V. (2007). Preparation and stability of cosmetic formulations with an anti-aging peptide. Journal of Cosmetic Science, 58(2), 157–171. https://pubmed.ncbi.nlm.nih.gov/17520155/
- Kornhauser, A., Wei, R. R., Yamaguchi, Y., Coelho, S. G., Kaidbey, K., Barton, C., Takahashi, K., Beer, J. Z., Miller, S. A., & Hearing, V. J. (2009). The effects of topically applied glycolic acid and salicylic acid on ultraviolet radiation-induced erythema, DNA damage and sunburn cell formation in human skin. Journal of Dermatological Science, 55(1), 10–17. https://doi.org/10.1016/j.jdermsci.2009.03.011
- The Ordinary. (n.d.). Multi-Peptide + HA Serum. Retrieved September 25, 2026, from https://theordinary.com/en-us/multi-peptide-ha-serum-100613.html